Climate Change Data

ITH Pharma Ltd

Climate Impact & Sustainability Data (2023-05 to 2024-04)

Reporting Period: 2023-05 to 2024-04

Environmental Metrics

Total Carbon Emissions:553.11 tCO2e/year
Scope 1 Emissions:4.96 tCO2e/year
Scope 2 Emissions:252.86 tCO2e/year
Scope 3 Emissions:295.29 tCO2e/year
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:80.06 tons/year
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Climate Change

Environmental Achievements

  • Reduced carbon emissions from 764.51 tonnes of CO2e in 2022/23 to 553.11 tonnes of CO2e in 2023/24

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Achieve Net Zero emissions by 2050
Medium-term Goals:
  • Achieve a 50% reduction in GHG emissions by 2030
Short-term Goals:
  • Reduce emissions by 47.78 tCO2e (6.25%) per year to achieve a 50% reduction by 2030

Environmental Challenges

  • High energy usage on site
  • Staff commuting emissions
  • Waste generation
Mitigation Strategies
  • Implementing energy-efficient machinery, equipment, and lighting
  • Encouraging ride-sharing, walking, and cycling to work
  • Exploring 'zero to landfill' waste solutions and reviewing packaging/goods used

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: ISO 14064:1-2018, GHG Protocol Accounting and Reporting Standards

Certifications: Null

Third-party Assurance: Carbon Neutral Britain Ltd

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed